Nomura Holdings
TLSI icon

Nomura Holdings’s TriSalus Life Sciences TLSI Stock Holding History

Nomura Holdings’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-401,757
Closed -$3.99M – 1709
2022
Q3 		$3.99M Hold
401,757
– – 0.02% 621
2022
Q2 		$3.95M Hold
401,757
– – 0.01% 621
2022
Q1 		$3.94M Buy
401,757
+297,357
+285% +$2.93M 0.01% 705
2021
Q4 		$1.03M Buy
104,400
+32,400
+45% +$322K ﹤0.01% 1200
2021
Q3 		$713K Hold
72,000
– – ﹤0.01% 1264
2021
Q2 		$703K Hold
72,000
– – ﹤0.01% 1200
2021
Q1 		$700K Buy
+72,000
New +$730K ﹤0.01% 1236

Other funds holding TLSI

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
DFCM
Dark Forest Capital Management San Juan, Puerto Rico $1.13B AUM 18.74% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Nomura Holdings's TLSI Position: Q4 2022 in Review

Nomura Holdings sold out of TriSalus Life Sciences (TLSI) in Q4 2022, closing a stake of 401,757 shares — an estimated $3.99M sold.

Nomura Holdings first reported a position in TLSI in Q1 2021 and held it in 7 quarters. The position peaked at $3.99M in Q3 2022. 9 funds tracked by Wall St. Rank hold TLSI as of Q4 2022.

  • Nomura Holdings reported no remaining TriSalus Life Sciences position as of Q4 2022 after selling out during the quarter.
  • Nomura Holdings sold 401,757 TriSalus Life Sciences shares in Q4 2022, an estimated $3.99M.
  • Nomura Holdings first reported a position in TriSalus Life Sciences in Q1 2021 and held it in 7 quarters.
  • Nomura Holdings's TriSalus Life Sciences position peaked at $3.99M in Q3 2022.
  • 9 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2022.

Based on Nomura Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.